Patents by Inventor James Kenneth Sutherland

James Kenneth Sutherland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4020172
    Abstract: The disclosure relates to a series of novel prostaglandin intermediates, the preparation of which in sequence constitutes a novel process for the manufacture of known diol intermediates, for example 2,3,3a.beta.,6a.beta.-tetrahydro-5.alpha.-hydroxy-4.beta.-(3-hydroxyoct-1- trans-enyl)-2-oxocyclopenteno[b]furan, from the readily available norbornadiene, said process comprising fewer and more easily operable stages than previously known processes for the manufacture of said diol intermediates.
    Type: Grant
    Filed: November 28, 1975
    Date of Patent: April 26, 1977
    Assignee: Imperial Chemical Industries Limited
    Inventors: Richard Philip Peel, James Kenneth Sutherland
  • Patent number: 3952019
    Abstract: The disclosure relates to a series of novel prostaglandin intermediates, the preparation of which in sequence constitutes a novel process for the manufacture of known diol intermediates, for example 2,3,3a.beta.,6a.beta.-tetrahydro-5.alpha.-hydroxy-4.beta.-(3-hydroxyoct-1- trans-enyl)-2-oxocyclopenteno[b]furan, from the readily available norbornadiene, said process comprising fewer and more easily operable stages than previously known processes for the manufacture of said diol intermediates.
    Type: Grant
    Filed: April 30, 1974
    Date of Patent: April 20, 1976
    Assignee: Imperial Chemical Industries Limited
    Inventors: Richard Philip Peel, James Kenneth Sutherland